← All organizations

Olema Pharmaceuticals, Inc.

For profit

Also known as: Olema Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Oct 31, 2025

Timeline

2000s

Jun 1, 2006
Olema Pharmaceuticals, Inc.— Founded

Drugs by trial phase (9 distinct, 6 trials)

Phase 3 (6 own, 0 via acquisition)

Phase 1 (3 own, 0 via acquisition)

Indications

Studied for

Breast Neoplasms

Recent trials (12)

NCT07085767OfficialPhase 3Oct 31, 2025
NCT07085767Lead sponsorPhase 3Oct 31, 2025
NCT06784193Lead sponsorPhase 1Dec 16, 2024
NCT06016738Study directorPhase 3Oct 10, 2023
NCT06016738Lead sponsorPhase 3Oct 10, 2023
NCT05508906Lead sponsorPhase 1Aug 31, 2022
NCT05508906Study directorPhase 1Aug 31, 2022
NCT05508906OfficialPhase 1Aug 31, 2022
NCT05266105Lead sponsorPhase 1Dec 10, 2021
NCT05266105Study directorPhase 1Dec 10, 2021
NCT04505826Study directorPhase 1/Phase 2Aug 13, 2020
NCT04505826Lead sponsorPhase 1/Phase 2Aug 13, 2020

Details

Founded: San Francisco, CA, US Jun 1, 2006
Last known activity: Oct 31, 2025